Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBNY
3201
PUT
DELISTED
Signature Bank
SBNY
| $3.68M | ﹤0.01% |
13,500
+10,500
| +350% | +$2.64M |
|
|
IIN
3202
DELISTED
IntriCon Corporation
IIN
| $3.66M | ﹤0.01% |
201,769
-41,695
| -17% | -$899K |
|
3203
PUT
Phillips 66
PSX
$97.4B
| $3.66M | ﹤0.01% |
52,300
+4,500
| +9% | +$326K |
|
|
AGTC
3204
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $3.66M | ﹤0.01% |
1,216,917
-534,401
| -31% | -$1.9M |
|
3205
Blue Owl Capital
OBDC
$5.57B
| $3.66M | ﹤0.01% |
259,378
+69,976
| +37% | +$1.01M |
|
|
TGP
3206
DELISTED
Teekay LNG Partners L.P.
TGP
| $3.66M | ﹤0.01% |
+235,429
| New | +$3.48M |
|
3207
CEVA Inc
CEVA
$764M
| $3.65M | ﹤0.01% |
85,661
+59,449
| +227% | +$2.7M |
|
|
ITMR
3208
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $3.65M | ﹤0.01% |
120,895
-265,717
| -69% | -$5.88M |
|
3209
Groupon
GRPN
$794M
| $3.65M | ﹤0.01% |
160,079
+72,737
| +83% | +$2.15M |
|
3210
Nabors Industries
NBR
$1.39B
| $3.65M | ﹤0.01% |
37,824
-3,241
| -8% | -$282K |
|
|
BSAQ.U
3211
DELISTED
Black Spade Acquisition Co Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
BSAQ.U
| $3.65M | ﹤0.01% |
+367,700
| New | +$3.66M |
|
3212
CALL
Rockwell Automation
ROK
$47.8B
| $3.65M | ﹤0.01% |
+12,400
| New | +$3.81M |
|
3213
Winnebago Industries
WGO
$865M
| $3.64M | ﹤0.01% |
50,237
+45,400
| +939% | +$3.17M |
|
|
OEPWU
3214
DELISTED
One Equity Partners Open Water I Corp. Unit
OEPWU
| $3.62M | ﹤0.01% |
365,002
-7,469
| -2% | -$74.2K |
|
3215
American Superconductor
AMSC
$1.38B
| $3.62M | ﹤0.01% |
248,184
+79,405
| +47% | +$1.1M |
|
3216
Onto Innovation
ONTO
$16.6B
| $3.62M | ﹤0.01% |
50,029
+22,594
| +82% | +$1.63M |
|
3217
Xenon Pharmaceuticals
XENE
$5.81B
| $3.61M | ﹤0.01% |
236,219
-65,529
| -22% | -$1.14M |
|
|
DHC
3218
Diversified Healthcare Trust
DHC
$1.85B
| $3.6M | ﹤0.01% |
1,062,575
-143,198
| -12% | -$540K |
|
3219
AnaptysBio
ANAB
$1.67B
| $3.6M | ﹤0.01% |
132,709
+25,189
| +23% | +$639K |
|
3220
CALL
Danaher
DHR
$152B
| $3.59M | ﹤0.01% |
13,310
-69,034
| -84% | -$18.8M |
|
|
ESM
3221
DELISTED
ESM Acquisition Corporation
ESM
| $3.59M | ﹤0.01% |
367,956
+135,120
| +58% | +$1.31M |
|
3222
CALL
Stryker
SYK
$127B
| $3.59M | ﹤0.01% |
13,600
-161,200
| -92% | -$43.1M |
|
3223
CALL
Cigna
CI
$73.7B
| $3.58M | ﹤0.01% |
17,900
+12,700
| +244% | +$2.76M |
|
3224
Monarch Casino & Resort
MCRI
$2.2B
| $3.58M | ﹤0.01% |
53,435
-2,997
| -5% | -$194K |
|
|
MDC
3225
DELISTED
M.D.C. Holdings, Inc.
MDC
| $3.58M | ﹤0.01% |
76,574
-249,658
| -77% | -$12.6M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.